?? ???? ?????? ???????? a high-risk stage II or operable stage III colon cancer, you still haven’t had colon cancer surgery or you have had it a few days ago, and you have other characteristics, you may be eligible to take part in the trial. ?? ?????? ???????? ??????????????????????, ???????????? ?????????????? ?????? ???????????? ???? ?????????????????? ?????????????? ??????: - ???? Consulta "La rete dei centri clinici": https://lnkd.in/djmpVq3y - ???? Consulta "La red clínica": https://lnkd.in/dZvdVBbQ - ???? Siehe "Das klinische Netzwerk der SAGITTARIUS-Studie": https://lnkd.in/d-JWZc73 - ???? Check "The clinical network": https://lnkd.in/dPQmhjjs #ColonCancer #SagittariusEU #SagittariusProject #coloncancercare #EUCancerMission #CancerResearch #CRC #LiquidBiopsy #ClinicalTrial #PersonalisedMedicine #CancerTreatment IFOM Fondazione AIRC per la Ricerca sul Cancro ETS Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universit?tsmedizin Berlin Ospedale Niguarda di Milano Fondazione Oncologia Niguarda Onlus Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA) European Commission
Sagittarius EU Project
公共卫生
Within the SAGITTARIUS project, researchers aim to optimise the clinical management of locoregional colon cancer.
关于我们
The overarching objective of SAGITTARIUS is to use liquid biopsy (LB), a new innovative assay for detecting the circulating tumour DNA (ctDNA) in the blood, to personalise the post-surgical care of patients with loco-regional stage III and high-risk stage II colon cancer (LRCC).
- 网站
-
https://www.sagittarius-horizon.eu/
Sagittarius EU Project的外部链接
- 所属行业
- 公共卫生
- 规模
- 11-50 人
- 类型
- 非营利机构
动态
-
#ECCAM25 is here and #??IYKYK. If you know, you know: ?? the challenges of colorectal cancer (CRC) ?? the fact that it is impacting younger and younger individuals ?? the risks, the symptoms and the misconceptions ?? the opportunities for screening and prevention! Talking about cancer should never be a taboo, especially not in professional circles. That is why, this month, colorectal cancer patients are telling their [mostly] unfiltered stories in their own words on our social media channels, including here, to talk about what everyone needs to know. Join the campaign and share their powerful stories with your network and help more people know more. #ECCAM2025 #ECCAM25 #IYKYK #CRC #ColorectalCancer
-
???????????????? ???????????????????? ???????????? ?????????????????? ?????????? (??????????) ???????? has officially started! So, are you ready to help us raise awareness about #ColorectalCancer? Then check out our website for more information on this year's campaign ?? https://lnkd.in/ebM-9y8v No one is too young for Colorectal Cancer,?and with #ECCAM2025 we want to show that CRC doesn’t wait but early intervention can save lives. #??IYKYK #CRC #ECCAM #ECCAM25 Mila Ogalla Toledo Andi Carlan Michael Kecht Aurelijus Veryga Gianluca Mauri Ospedale Niguarda di Milano Eric Van Cutsem Lieve Wierinck Eric Grant Union for International Cancer Control (UICC) Colon Cancer Coalition Colon Cancer Prevention Project Colon Cancer Foundation Fight Colorectal Cancer Colorectal Cancer Alliance Colorectal THRIVE Colorectal Cancer Canada EU Health and Food Safety EU Science, Research and Innovation Youth Cancer Europe European Network of Youth Cancer Survivors Youth Cancer Trust European Youth Forum Youth Cancer Alliance Ruel Jacob Marianna Vitaloni, Ph.D. European Parliament European Parliamentary Research Service
-
?? Your Journey Matters! Help Transform Colon Cancer Care! | See below for ???? ???? ???? ???? | ???? Your experience is unique and so should be your care. By joining our clinical trial, you’re not just taking part in research. You’re also helping to create a future where cancer treatment is truly personalised. Your voice, your journey, and your participation can lead to better, more tailored care for patients like you. Together, we can improve treatment outcomes and make a real difference. ?? Contact?[email protected]?or visit?https://lnkd.in/ehy55__6?to learn more and get involved today. ???? La vostra esperienza è unica e così dovrebbe essere la vostra cura. Partecipando al nostro studio clinico, non vi limitate a prendere parte alla ricerca. State anche contribuendo a creare un futuro in cui il trattamento del cancro sia veramente personalizzato. La vostra voce, il vostro percorso e la vostra partecipazione possono portare a cure migliori e più personalizzate per pazienti come voi. Insieme, possiamo migliorare i risultati delle cure e fare la differenza. ?? Contattate?[email protected]?o visitate il sito?https://lnkd.in/ehy55__6?per saperne di più e verificare se potete partecipare. ???? Vuestra experiencia es única y también debería serlo vuestra atención. Al unirse a nuestro ensayo clínico, no sólo participa en la investigación. También está ayudando a crear un futuro en el que el tratamiento del cáncer sea realmente personalizado. Su voz, su relato, y su participación pueden conducir a una atención mejor y más personalizada para personas como usted. Juntos, podemos mejorar los resultados del tratamiento y marcar una verdadera diferencia. ?? Contacte a?[email protected]?o visite?https://lnkd.in/ehy55__6?para obtener más información y comprobar si pudieras participar. ???? Ihre Erfahrungen sind einzigartig, und so sollte auch Ihre Behandlung sein. Wenn Sie an unserer klinischen Studie teilnehmen, nehmen Sie nicht nur an der Forschung teil. Sie tragen auch dazu bei, eine Zukunft zu schaffen, in der die Krebsbehandlung wirklich personalisiert ist. Ihre Stimme, Ihre Geschichte und Ihre Teilnahme k?nnen zu einer besseren, ma?geschneiderten Behandlung für Menschen wie Sie führen. Gemeinsam k?nnen wir die Behandlungsergebnisse verbessern und einen echten Unterschied machen. ?? Kontaktieren Sie?[email protected]?oder besuchen Sie?https://lnkd.in/ehy55__6, um mehr zu erfahren und zu sehen, ob Sie teilnehmen k?nnen. IFOM Digestive Cancers Europe Europacolon Portugal Charité - Universit?tsmedizin Berlin Vall d'Hebron Institute of Oncology (VHIO) ECRIN (European Clinical Research Infrastructure Network) Bowel Cancer UK Cancer Research UK (CRUK) Deutsche Krebsgesellschaft e. V. (German Cancer Society) AIRC - Foundation for Cancer Research NGO Hospital del Mar ESMO - European Society for Medical Oncology Hans Kluge Marina Zanchi
-
-
???Highlights from World Cancer Day event in Biella ???At the recent event in Biella for World Cancer Day, about cutting-edge innovations against cancer,?Dr. Silvia Marsoni (IFOM) presented SAGITTARIUS. The question:?“How can we identify non-metastatic colon cancer cases that don’t require further treatment after surgery?”. The possible solution explored in the SAGITTARIUS trial:?personalized, tumour-based?liquid biopsies to - hopefully - better address each patient's needs.??? ???Biella’s healthcare system plays a key role in providing data for SAGITTARIUS, as highlighted by Dr. Francesco Leone, Director of Oncology and SAGITTARIUS Principal Investigator?at the Azienda Sanitaria Locale (ASL) of Biella. In fact, the ASL of Biella is part of the clinical network of the SAGITTARIUS project and was one of the first clinical centres of the project to enroll patients. ?? Learn more about?SAGITTARIUS:?https://lnkd.in/ehy55__6 #SagittariusEU?#SagittariusProject?#CRC?#ColonCancerCare?#HorizonEU?#EUCancerMission? AIRC - Foundation for Cancer Research NGO?Università Bocconi?Hospital del Mar?Digestive Cancers Europe?SporeData Inc.?Vall d'Hebron Institute of Oncology (VHIO) Charité - Universit?tsmedizin Berlin?European Commission?European Health and Digital Executive Agency (HaDEA)?
-
-
-
-
-
+1
-
-
???????Come funziona lo studio clinico SAGITTARIUS? ???Guarda il video per scoprire come il trial mira a personalizzare la terapia post-chirurgica in alcuni pazienti con tumore al colon e per capire se potresti essere candidabile al trial. ???Se hai un tumore al colon di stadio II ad alto rischio o di stadio III operabile e non hai ancora ricevuto la chirurgia, oppure l’hai ricevuta da non più di una settimana, prova a contattare uno dei centri di riferimento per maggiori informazioni e valuta le possibilità di partecipare insieme al tuo medico: https://lnkd.in/edqqJdZM Full video: https://lnkd.in/euCdprjg IFOM AIRC - Foundation for Cancer Research NGO Università Bocconi Hospital del Mar Research Institute Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universit?tsmedizin Berlin European Commission European Union Ospedale Niguarda di Milano Fondazione Ospedale Niguarda
-
Today, we celebrate the International Day of Women & Girls in Science. Learn about some of the women working with us on different science, research and innovation projects. ??Marianna Vitaloni, Ph.D., a passionate patient advocate and coordinator of medical and scientific initiatives at DiCE, among which TOGAS EU project ?? https://lnkd.in/epEMr2UM ????Nadia Saoudi Gonzalez, a colorectal cancer researcher, and Ylenia Silvestri, PhD, a clinical project manager, working on #CRC research within Sagittarius EU Project ?? https://lnkd.in/ekiFGScF ?? Ana M. Miralles Marco, Project Manager of AIDA EU project and coordinating cutting-edge research to improve cancer care?? https://lnkd.in/eWFScaFN #WomenInScience #WomenInSTEM Women in Science International Women in Science (IWiSci) Day Conference International Women's Day UN Women Europe and Central Asia EU Health and Food Safety EU Science, Research and Innovation
-
-
?? Celebrating Women in Science: Meet Nadia & Ylenia On the International Day of Women and Girls in Science, we proudly highlight two incredible women driving innovation in the SAGITTARIUS project: Nadia Saoudi Gonzalez and Ylenia Silvestri, PhD. ?? Nadia, a colorectal cancer researcher, shares: "My dedication to colorectal cancer research is inspired by the challenges I have witnessed in patients and their families. These experiences drive my pursuit of advancements that enhance both clinical outcomes and quality of life." ?? Ylenia, a clinical project manager, adds: "The opportunity to help redefine cancer treatment and improve countless lives is what drives me every day. Precision oncology is revolutionising cancer care, and being part of this transformative journey is both an honour and a responsibility." Their work exemplifies the passion, dedication, and impact of women in science. Let’s continue to support and empower women and girls in research, shaping the future of science! ?? IFOM AIRC - Foundation for Cancer Research NGO Università Bocconi Hospital del Mar Hospital del Mar Research Institute Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) chariteberlin Ospedale Niguarda di Milano Fondazione Oncologia Niguarda Onlus Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA) European Commission European Parliament
-
-
?? Why does post-surgical care still follow a one-size-fits-all approach? Every cancer journey is unique. Yet, treatment decisions after colon cancer surgery are often based on standard protocols rather than a patient’s individual needs. This #WorldCancerDay, we ask: Can we do better? The SAGITTARIUS clinical trial is exploring a new, personalised approach using liquid biopsy - a simple blood test that detects signs of cancer after surgery. Instead of relying on standard treatment protocols, this could help tailor post-surgical care to each patient’s needs, ensuring: ?? The right treatment at the right time ?? Fewer unnecessary side effects ?? Better post-surgical outcomes This approach could be life-changing - because cancer care should focus on the person, not just the disease. Do you agree that we need more personalised care? #cancerawareness #UnitedByUnique?#healthinnovation #futureofhealthcare Union for International Cancer Control (UICC) European Commission European Parliament IFOM AIRC - Foundation for Cancer Research NGO Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) chariteberlin ?European Health and Digital Executive Agency (HaDEA)
-
-
In occasione del #WorldCancerDay, Salute24 Il Sole 24 Ore si occupa della lotta contro queste patologie purtroppo molto diffuse che, tuttavia, è possibile combattere efficacemente innanzitutto con prevenzione e diagnosi precoce. Nicoletta Carbone ne parla con Alberto Bardelli, raccontando le ricerche in corso in IFOM con il sostegno di Fondazione AIRC per la Ricerca sul Cancro ETS. Qui l'intervista: ?? https://lnkd.in/dmUwFEFT
-